Department of Surgery, Houston Methodist Hospital, 6550 Fannin Street, Houston, TX, 77030, USA.
Department of General Surgery, Weill Cornell Medical College, New York, NY, USA.
Obes Surg. 2021 Aug;31(8):3436-3443. doi: 10.1007/s11695-021-05435-5. Epub 2021 May 4.
Severe obesity can increase risk of complications after kidney transplantation. There is a paucity of literature on bariatric surgery outcomes in renal transplant candidates. The objective of this study was to analyze outcomes of bariatric surgery as a weight reduction strategy for patients with kidney failure to enhance eligibility for kidney transplantation.
We performed a retrospective analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database at a single institution for patients with chronic kidney disease receiving hemodialysis therapy (CKD G5D) undergoing bariatric surgery between 2011 and 2018.
Of 2363 patients who underwent bariatric surgery, 38 (1.6%) had CKD G5D; median age (range) was 49 years (33; 69), 52.6% were female, and mean BMI was 44.2 kg/m. Twenty-four patients underwent laparoscopic Roux-en-Y gastric bypass (LRYGB), and 14 patients underwent laparoscopic sleeve gastrectomy. Seventeen patients (46%, n=37) had a BMI≤35 at 6 months, while 25 patients (75.8%, n=33) achieved a BMI≤35 at 12 months. Of these, 18 patients (47%) were listed for kidney transplant, and 8 patients (21%) received kidney transplant. There was no statistically significant difference between sleeve and LRYGB procedures in patients who reached BMI of 35 at 12 months (P=0.58). Median length of stay was 2.3 days. Thirty-day readmission rate was 2 patients (5.3%), and 2 patients (5.3%) required reoperation (one for bleeding, one for acute recurrent hiatal hernia). No mortality occurred.
Laparoscopic bariatric surgery offers effective weight loss for CKD G5D patients to achieve transplant eligibility with acceptable outcomes.
严重肥胖会增加肾移植后并发症的风险。关于肥胖症患者接受肾移植候选人的减肥手术结果的文献很少。本研究的目的是分析减肥手术作为肾衰竭患者增强肾移植资格的减肥策略的结果。
我们对一家机构的代谢和减肥手术认证和质量改进计划数据库进行了回顾性分析,该数据库纳入了 2011 年至 2018 年间接受血液透析治疗的慢性肾脏病(CKD G5D)患者,这些患者接受了减肥手术。
在 2363 名接受减肥手术的患者中,有 38 名(1.6%)患有 CKD G5D;中位年龄(范围)为 49 岁(33-69),52.6%为女性,平均 BMI 为 44.2kg/m2。24 名患者接受腹腔镜 Roux-en-Y 胃旁路术(LRYGB),14 名患者接受腹腔镜袖状胃切除术。17 名患者(46%,n=37)在 6 个月时 BMI≤35,25 名患者(75.8%,n=33)在 12 个月时 BMI≤35。其中 18 名患者(47%)被列入肾脏移植名单,8 名患者(21%)接受了肾脏移植。在达到 12 个月时 BMI 为 35 的患者中,袖状胃切除术和 LRYGB 手术之间无统计学差异(P=0.58)。中位住院时间为 2.3 天。30 天再入院率为 2 名患者(5.3%),2 名患者(5.3%)需要再次手术(1 例出血,1 例急性复发性食管裂孔疝)。无死亡发生。
腹腔镜减肥手术为 CKD G5D 患者提供了有效的体重减轻,以达到可接受的结果,从而获得移植资格。